None listed
Conditions
Brief summary
PRECISION-SAH is a national research project focused on improving care for patients admitted to ICUs with a serious type of brain bleed called aneurysmal subarachnoid haemorrhage (aSAH). Although medical care for this condition has improved over time, many patients still face serious risks, including brain damage and death. PRECISION-SAH will collect detailed clinical information from patients at hospitals around Australia. The goal is to understand how different hospitals manage care, identify which treatments work best, and find early warning signs of DCI.
Interventions
This is an observational study, there is no intervention. The study will collect data from patients who are diagnosed with an aneurysmal subarachnoid haemorrhage (aSAH), a serious type of brain bleed which is associated with high mortality and long-term disability. The study will collect data about patient demographics, medical history, initial presentation with aSAH (clinical presentation, SAH symptoms and grading), daily ICU data (e.g. physical and neurological assessments, vital signs, imagin
This is an observational study, there is no intervention. The study will collect data from patients who are diagnosed with an aneurysmal subarachnoid haemorrhage (aSAH), a serious type of brain bleed which is associated with high mortality and long-term disability. The study will collect data about patient demographics, medical history, initial presentation with aSAH (clinical presentation, SAH symptoms and grading), daily ICU data (e.g. physical and neurological assessments, vital signs, imaging), management of the patient and neurological outcome after the event. The required data during hospitalisation are already being collected during routine clinical care. Patients and/or their next of kin will be asked to complete a follow-up telephone interview 6-months post-enrolment. This will take approximately 30 minutes and include 3 assessments (modified Rankin scale, Subarachnoid Haemorrhage Outcome Tool and EQ-5D-5L). The overall duration of observation is 6 months.
Sponsors
Monash University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
- Clinical diagnosis of aneurysmal subarachnoid haemorrhage (aSAH) - Admitted to the ICU with or without invasive neuromonitoring as per the treating clinical team
Exclusion criteria
- Admission to the ICU solely for the purposes of palliative care or confirmation of organ donation - Advanced care directive or previously stated wish not to be included in research activities
Outcome results
None listed